Hormonal and non-hormonal interventions for menopausal symptoms

Maturitas

Volumn 23, Issue 2, 1996, Pages 159-168

  Coope, Jean ^a  

^a Bollington Medical Centre   (United Kingdom)

Author keywords

Exercise; Menopause; Oestrogen; Paced respiration; Progestogen; Psychotherapy

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; EXERCISE; FEMALE; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; MENOPAUSAL SYNDROME; PSYCHOTHERAPY;

EID: 0030014774     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(95)00971-X     Document Type: Conference Paper

References (74)

1. Ballinger CB. Psychiatric morbidity and the menopause: screening of a general population sample. Br Med J 1975; 9: 344-346.
2. McKinlay S. Jeffreys M. The menopausal syndrome. Br J Prev Soc Med 1974; 28: 108-115.
3. Jaszmann LJ. Epidemiology of the climacteric syndrome. In: Campbell S, ed. The Management of the Menopause and Post-Menopausal Years. MTP Press, Lancaster, England, 1976, pp. 11-23.
4. Bungay GT, Vessey M, McPherson CK. Study of symptoms in middle life with special reference to the menopause. Br Med J 1980; 281: 181-183.
5. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Am J Hum Biol 1992; 4: 37-46.
6. Hunter MS. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992; 14: 117-126.
7. Holte A. Influences of natural menopause on health complaints: a prospective study of healthy Norwegian women, Maturitas 1992; 14: 127-141.
8. Kaufert PA, Gilbert P, Tate R. The Manitoba Project: a re-examination of the link between menopause and depression. Maturitas 1992; 14: 143-155.
9. Lock M. Contested meanings of the menopause. Lancet 1991; 337: 1270-1272.
10. Martin MC et al. Menopause without symptoms: the endocrinology of menopause among rural Mayan Indians. Am J Obstet Gynecol 1993; 168: 1839-1843.
11. Greene JG. The cross-sectional legacy: an introduction to longitudinal studies of the climacteric. Maturitas 1992; 14: 95-101.
12. Sturdee OW, Wilson KA, Pipili E, Crocker D. Physiological aspects of menopausal hot flush. Br Med J 1978; 2: 79-80.
13. Ginsburg J, Hardiman P, O'Reilly B. Peripheral blood flow in menopausal women who have hot flushes and in those who do not. Br Med J 1989; 298: 1488-1489.
14. Ginsburg J, Hardiman P, Nihoyannopoulos P. Cardiovascular effects of transdermal oestradiol in postmenopausal women. In Int. Congress on the Menopause, Bangkok. Parthenon Publishing Group, Carnforth, England, 1990, Abstract 50.
15. Utian WH. The true clinical features of postmenopause and oophorectomy and their response to oestrogen therapy. S Afr Med J 1972; 46: 732-737.
16. Coope J, Thomson J. Effects of "natural oestrogens" on menopausal symptoms and blood clotting. Br Med J 1975; 4: 139-143.
17. Bullock JL et al. Use of medroxy-progesterone acetate to prevent menopausal symptoms. Obstet Gynaecol 1975; 46: 165-168.
18. Campbell S. Double blind psychometric studies on the effects of natural estrogens on the post-menopause woman. In Campbell S, ed. The Management of the Menopause and Post-Menopausal Years. MTP Press, Lancaster, England, 1976.
19. Keller PJ, Hotz E, Imthurn B. A transdermal regimen for continuous combined hormone replacement therapy in the menopause. Maturitas 1992; 15: 195-198.
20. Høvik P, Sundsbak HP, Gaasemyr M, Sandvik L. Comparison of continuous and sequential oestrogen-progestogen treatment in women with climacteric symptoms. Maturitas 1989; 11: 75-82.
21. Meuwissen JHJM, van Langen H, Moret E, Navarro-Morquencho I. Monitoring of oestrogen replacement therapy in vaginosonography of the endometrium. Maturitas 1992; 15: 33-37.
22. Koniwckx PR, Lauweryns JM, Cornvillie FJ. Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate/cyproterone acetate preparation. Maturitas 1993; 16 (2): 97-110.
23. Casper RF, Chapdelaine A. Estrogen and interrupted progestin: a new concept for menopausal hormone replacement therapy. Am J Obstet Gynecol 1993; 168: 1188-1196.
24. Ettinger B. Using every three month progestin. Br J Obstet Gynaecol 1994; 101: 170-174.
25. Ellerington MC, Whitcroft SIJ, Whitehead MI. HRT: Developments in therapy. Br Med Bull 1992; 48 (2): 401-425.
26. Hillard TC, Siddle NC, Whitehead MI et al. Continuous combined conjugated equine oestrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis. Am J Obstet Gynecol 1992; 167 (1): 1-7.
27. Rees M, Leather A, Pryse-Davies J et al. A first study to compare two doses of dydrogesterone in opposing the 50 mg oestradiol implant. Maturitas 1991; 14: 9-15.
28. Benedek-Jaszmann LJ. Long-term placebo controlled efficacy and safety study of Org OD 14 in climacteric women. Maturitas 1987; Suppl. 1: 25-33.
29. Cittadini J, Ben J, Badano AR et al. The use of a new steroid (Org OD 14) in the climacteric syndrome. Reproduction 1982; 6: 69-79.
30. Hammar M, Berg C, Lindgren R. Does physical exercise influence the frequency of postmenopausal hot flushes? Acta Obstet Gynecol Scand 1990; 69: 19/495/7/90.
31. Freedman BR, Woodward S. Behavioural treatment of menopausal hot flushes: evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992; 167 (2): 436-439.
32. Hunter M. Personal communication. Unit of Psychiatry Guy's Hospital, London, England.
33. Coope J, Williams S, Patterson JS. A study of the effectiveness of propanolol in menopausal hot flushes. Br J Obstet Gynaecol 978; 85: 471-475.
34. Kronenberg F, Barnard RM. Modulation of menopausal hot flushes by ambient temperature. J Therm Biol 1991; 17: 43-49.
35. Uzan S, Salat-Baroux J. The menopause: vasomotor flushing, physio-pathology and treatment. Fr Gynecol Obstet 1986; 81 (8): 407-412.
36. Hallstrom T. Mental disorder and sexuality in the climacteric Stockholm. Scandinavian University Books, Esselte Studium, 1973.
37. Leiblum S, Bachmann G. The sexuality of the climacteric woman. In: Eskin BA, ed. The Menopause: Comprehensive Management, 2nd Ed. Macmillan Publishing Co, New York, USA, 1988.
38. Pfeiffer E, Davis GC. Determinants of sexual behavior in middle and old age. J Am Geriatr Soc 1972; 20: 151-158.
39. Gordon H. The correlation of menopausal symptoms with cytohormonal status. In: Campbell S, ed. The Management of the Menopause and Post-Menopausal Years. MTP Press, Lancaster, England, 1976.
40. Marsh MS, Whitehead MI. Management of the Menopause. Br Med Bull 1992; 48 (2): 426-457.
41. Dennerstein L, Burrows G. Sexual response following hysterectomy and oophorectomy. Obstet Gynecol 1977; 49: 92-96.
42. Carney A, Bancroft J, Matthews A. Combination of hormonal and psychological treatment for female sexual unresponsiveness: a comparative study. Br J Psychiatry 1978; 132: 339-346.
43. Burger H, Hailes J, Nelson J, Menelaus M. Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women. Br Med J 1987; 294: 936-937.
44. Rekers H, Drogendijk AC, Valkenburg HA, Riphagen F. The menopause, urinary incontinence and other symptoms of the genito-urinary tract. Maturitas 1991; 15: 101-111.
45. Yarnell JWG, Boyle GJ, Richard CJ, Stephenson TP. The prevalence and severity of urinary incontinence in women. J Epidemiol Commun Health 1981; 35: 71-74.
46. Diokno AC, Brock BM, Brown MB, Herzog AR. Prevalence of urinary incontinence and other urological symptoms in the non-institutionalized elderly. J Urol 1986; 136: 1022-1025.
47. Samsioe G, Jansson I, Mellstrom D, Svandborg A. Occurrence, nature and treatment of urinary incontinence in a 70 year old female population. Maturitas 1985; 7: 335-342.
48. Foidart JM, Vervliet J, Buytaert PH. Efficacy of sustained-release vaginal oestriol in alleviating urogenital and systemic climacteric complaints. Maturitas 1991; 15: 99-107.
49. Cardozo L. Role of estrogens in the treatment of female urinary incontinence. J Am Geriatr Soc 1990; 38: 326-328.
50. Ahlstrom K, Sandahl B, Sjobert B et al. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone in postmenopausal women with stress urinary incontinence. Gynecol Obstet Invest 1990; 3: 37-43. N Engl J Med 1993; 329: 802-803.
51. Ahlstrom K, Sandahl B, Sjobert B et al. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone in postmenopausal women with stress urinary incontinence. Gynecol Obstet Invest 1990; 3: 37-43. N Engl J Med 1993; 329: 802-803.
52. Raz R, Stamm WE. A controlled trial of intra-vaginal estriol in post-menopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329: 802-803.
53. Brincat M, Versi E, O'Dowd I et al. Skin collagen changes in post-menopausal women receiving oestradiol gel. Maturitas 1987; 9 (1): 1-5.
54. Bacho C, Winandy A. A preliminary study of the hormonal effect on various parameters of the pelvic floor in genitally active women without hormone therapy and in menopausal women. Acta Urol Belg 1992; 60 (2): 45-60.
55. Smith P, Heimer G, Lindskog M, Ulmsten Ulf. Oestradiol-releasing vaginal ring for treatment of post-menopausal urogenital atrophy. Maturitas 1991; 16: 145-154.
56. Erlik U, Tataryn IV, Meldrum DR et al. Association of waking episodes with menopausal hot flushes. J Am Med Assoc 1981; 245 (17): 1741-1744.
57. Thomson J, Oswald I. Effect of oestrogen on the sleep, mood and anxiety of menopausal women. Br Med J 1977; 2: 1317-1319.
58. Jenkins R, Clare AW. Women and mental illness. Br Med J 1985; 291: 1523-1524.
59. McEwen BS et al. Steroid hormones: humoral signals which alter brain cell properties and function. Recent Prog Hormone Res 1982; 38: 41.
60. Coope J. Is oestrogen therapy effective in the treatment of menopausal depression. J R Coll GP 1981; 31: 134-140.
61. Montgomery JC, Appleby L, Brincat M et al. Effect of oestrogen and testosterone implants on psychological disorders of the climacteric. Lancet 1987; i: 297-299.
62. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992; 80 (1): 30-36.
63. Rauramo L, Lagerspetz K, Engblom P, Punnonen R. The effects of castration and peroral estrogen therapy on some psychological functions. In Estrogens in the Post-Menopause. Front Hormone Res., Vol. 3, p. 94, Karger, Basel, 1975.
64. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic post-menopausal women. Obstet Gynecol 1991; 78 (6): 991-995.
65. Highfield R. Science Editor, Daily Telegraph, November 1993. 'HRT can reduce Alzheimer risk say scientists!.
66. Coope J, Roberts. A clinic for the prevention of osteoporosis in general practice. Br J Gen Pract 1990; 40: 295-299.
67. Barrett-Connor E, Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. J Am Med Assoc 1993; 269 (20): 2637-2641.
68. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. Br Med J 1993; 306: 558.
69. Capell HA, MacDonald AG, Murphy EA et al. Effects of hormone replacement therapy (HRT) in rheumatoid arthritis (RA): a placebo-controlled study. In 57th Annu Meeting Am CoIl Rheumatology, San Antonio, USA, 1993, Abstract 228.
70. Hall GM, Spector TD. Hormone replacement therapy (HRT) suppresses disease activity in rheumatoid arthritis (RA): a randomised study of 200 patients. In 57th Annu Meeting Am CoIl Rheumatology, San Antonio, USA, 1993, Abstract 255.
71. van den Brink HR, van Everdingen AA, van Wijk MJG et al. Adjuvant oestrogen therapy does not im-prove disease activity in postmenopausal patients with rheumatoid arthritis. Ann Rheum Dis 1993; 52: 862-865.
72. Wilcox G, Wahlqvist ML, Burger HG, Medley G. Oestrogenic effects of plant foods in postmenopausal women. Br Med J 1990; 301: 905-906.
73. Jick H, Porter J, Morrison AS. Relation between smoking and age of natural menopause. Lancet 1977; 1:1354-1355.
74. Jensen J, Christiansen C, Rodbrø P. Cigarette smoking, serum oestrogens, and bone loss during hormone replacement therapy early after menopause. N Engl J Mad 1985; 313 (16): 973-975.